Dealbreaker on MSN
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario
Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial ...
Medidata Patient Experience will accelerate CTI’s treatments for patients with oncology, metabolic, cardiovascular, central ...
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...
The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials.
The once-daily oral drug, a SARS-CoV-2 main protease inhibitor developed by Shionogi, is registered in Japan and Singapore ...
Bio-Techne (TECH) and Nucleai announced the presentation of pivotal data from the SECOMBIT clinical trial at the Society for Immunotherapy of ...
As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...
Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of ...
Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...
Iovance Biotherapeutics shares rose after the company received positive data from a clinical trial of its cancer treatment. Shares traded 11% higher ahead of the morning bell at $2.18.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results